Top cyclist Jakob Fuglsang took to social media on Monday to contest links to disgraced Italian doctor Michele Ferrari, in response to reports of an investigation into the Olympic road race silver medallist.
Reports in Denmark say the Cycling Anti-Doping Foundation (CADF) has detailed accounts of alleged links between the Danish cyclist and the banned doctor, but the
International Cycling Union (UCI) says it has yet to see any report. Fuglsang's team Astana has denied knowledge of the links, saying in a statement it "does not collaborate with any suspicious doctor, such as Dr Michele Ferrari."
"Accordingly I have no case to answer. I am extremely concerned that such rumours could be spread out in the press."
Earlier on Monday, former Danish cyclist Brian Holm said the reports into links between Fuglsang and Ferrari were rumours that had been circulating since "last spring."
- 'Idiots trying their luck' -
==============================
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app